67 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
counter-party in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging … activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if any) could reduce the value
424B5
6gb5244p
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
55d7jhrn9oz
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
ubqazlu 6vsvka
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
yti3uex2m62bfy0
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
gr793n3gui9bwjej
28 Mar 22
Prospectus supplement for primary offering
4:53pm